FEATURED ACTIVITIES

Brought to you by PleXus Communications and Rush University Medical Center

Improving Survival for Veterans with Bladder Cancer – Translating New Knowledge into Clinical Practice

Faculty
Matthew D. Galsky, MD, FASCO
Professor of Medicine
Acting Chief, Division of Hematology and Medical Oncology
Icahn School of Medicine at Mount Sinai
Associate Director of Translational Research
Tisch Cancer Institute
New York, NY


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Optimizing the Care of Mantle Cell Lymphoma: Translating the Latest Advances into Clinical Practice

Faculty
Jonathon B. Cohen, MD, MS
Associate Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine
Co-Director, Lymphoma Program
Winship Cancer Institute of Emory University
Medical Director, Infusion Services
Winship Cancer Institute of Emory University
Atlanta, Georgia


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Optimizing Outcomes in Non-Small Cell Lung Cancer: Advances in the Management of EGFR-Mutated Disease

Faculty
Stephen V. Liu, MD
Associate Professor of Medicine,
Director of Thoracic Oncology and Director of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center
Washington, DC


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Best Clinical Practices for Optimizing the Use of BTK Inhibitors for the Treatment of CLL

Faculty
Matthew Davids, MD, MMSc
Director of Clinical Research, Division of Lymphoma
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, MA


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



β-Thalassemia in 2021: Overview of the Disease and its Management, Including Novel Therapies in Development

Faculty
Sujit Sheth, MD
Chief, Division of Pediatric Hematology/Oncology
Weill Cornell Medical Center
New York, NY


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Hormone Receptor-Positive Breast Cancer: Individualizing Therapy with CDK 4/6 Inhibitors

Faculty
Komal Jhaveri, MD, FACP
Attending, Breast Medicine and Early Drug Development Service
Section Head, Endocrine Therapy Program
Clinical Director, Early Drug Development Service
Memorial Sloan Kettering Cancer Center
Assistant Professor, Weill Cornell Medical College
NY, NY


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Applying Recent Advances in Treating Relapsed or Refractory Multiple Myeloma Into Real World Practice

Faculty
C. Ola Landgren, MD, PhD
Professor, Leader of Experimental Therapeutics Program & Leader of Myeloma Service
Sylvester Comprehensive Cancer Center
University of Miami Health System
Miami, FL


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Emerging Cellular and Targeted Therapy Options for the Management of Large B-Cell Lymphoma

Faculty
Caron Jacobson, MD
Medical Director, Immune Effector Cell Therapy Program
Senior Physician
Assistant Professor of Medicine, Harvard Medical School
Dana-Farber Cancer Institute
Boston, MA


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Navigating the Continuum of Care for Advanced Prostate Cancer (mCSPC, CRPC)

Faculty
Matthew Rettig, MD
Professor of Medicine and Urology
David Geffen School of Medicine at UCLA
Chief, Division of Hematology-Oncology, VA GLAHS
Los Angeles, CA


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Understanding Evolving Treatment Strategies in Newly Diagnosed Multiple Myeloma Patients

Faculty
Benjamin Derman, MD
Assistant Professor of Medicine
University of Chicago Medical Center
Chicago, Illinois


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Shifting Paradigms in the Management of Advanced Urothelial Carcinoma

Faculty
Ulka Vaishampayan, MD
Chair of Phase I therapy
GU Medical Oncology
Professor Internal Medicine
University of Michigan
Ann Arbor, MI


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Expert Perspectives on Optimizing Outcomes with the Latest Advances in Small Molecule Inhibitors for Chronic Lymphocytic Leukemia

Faculty
Matthew S. Davids, MD, MMSc
Clinical Research Director, Division of Lymphoma
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, MA


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Management of Waldenström’s Macroglobulinemia in the Era of Targeted Therapies

Faculty
Steven P. Treon, MD, MA, PhD
Professor of Medicine, Harvard Medical School
Director, Bing Center for Waldenström’s Macroglobulinemia
Dana Farber Cancer Center
Boston, MA


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



The Evolving Treatment Landscape for Higher-Risk Myelodysplastic Syndrome

Faculty
Jamile M. Shammo, MD, FASCP, FACP
Professor of Medicine and Pathology
Director of MDS/MPN/Aplastic Anemia Program
Rush University Medical Center
Chicago, IL


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center


Faculty
Matthew Rettig, MD
Professor of Medicine and Urology
David Geffen School of Medicine at UCLA
Chief, Division of Hematology-Oncology, VA GLAHS
Los Angeles, CA


Optimizing Care of Veterans with Advanced Renal Cell Carcinoma: Incorporating Immunotherapies and Targeted Agents into Clinical Practice


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



Advances in Cervical Cancer: Addressing Unmet Needs in an Evolving Therapeutic Landscape

Faculty
Robert L. Coleman, M.D., FACOG, FACS
Gynecology/Oncology
US Oncology Research
Texas Oncology
Texas, United States


Specialty: Oncology
Accreditation: 1.0 CME/CNE/CPE
Accredited Provider: Rush University Medical Center



© Copyright 2022